Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide
US11786579B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2019 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Mar 28, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2005/3128
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel injectable presentations, kits or syringes comprising a composition with sustained or controlled release of lanreotide or one of the salts thereof. The compositions of lanreotide or one of the salts thereof are packaged in a syringe having a diameter greater than 3.00 mm and provided with a needle having an outer diameter no greater than 1.00 mm.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.